Carvedilol plus ivabradine improves LVDD, survival in cirrhosis
The combination of ivabradine and carvedilol improves left ventricular diastolic dysfunction (LVDD), achieves targeted heart rate reduction (THR) more often, and reduces the risk of encephalopathy, leading to improved survival in patients with cirrhosis, reveals a study.